FDA Approves First Generic Forms of MS Drug Gilenya

FRIDAY, Dec. 6, 2019 -- The first generic versions of the multiple sclerosis drug Gilenya have been approved by the U.S. Food and Drug Administration.

The three generic versions of Gilenya (fingolimod) capsules were approved for the treatment of relapsing forms of multiple sclerosis (MS) in adults.

Could MS Have Links to the Herpes Virus?

MONDAY, Dec. 2, 2019 -- A variant of a common herpes virus may play a role in the development of multiple sclerosis (MS), Swedish researchers say.

They analyzed the blood of about 8,700 MS patients and a control group of more than 7,200 people without MS. They were looking for antibodies against proteins of two variants (A and B) of human herpesvirus 6 (HHV-6), which has been linked with MS.